Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,647.2
-5.4 (-0.21%)

 

  • STI Straits Times Index
    2,647.2
    -5.4 (-0.21%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,601.5
    9.7 (0.61%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,019.5
    292.1 (1.14%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,438.6
    55.3 (1.63%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,742.2
    451.4 (2.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,043.7
    12.5 (0.25%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 944.5M
  • Value: 573.9M
  • Rise: 143
  • Fall: 188
  • Unch: 477

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.002
Medtecs Intl0.880+0.010
Clearbridge0.205+0.020
MDR0.001-
Singapore-eDev0.128-0.002
Adventus0.026+0.001
Biolidics0.520+0.110
AsiaMedic0.032+0.001
Rex Intl0.177-
SinoCloud0.001-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KEROS THERAPEUTICS INC KEROS THERAPEUTICS
Updated on 10 Jul 2020 (End of trading day)
Last (USD): 32.750 Change: -0.680 High: 33.580 Remarks: -
Change (%): -2.03 Low: 31.360
Open 33.190 Yesterday's Close 33.43
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 101,381 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.70158 Trailing EPS (USD) e -0.70158 NAV (USD) b -1.2342
PE a - Trailing PE f - Price / NAV b -26.5354
Dividend (USD) d - Cash In Hand (USD) g 2.7058 Issued & Paid-up Shares c 20,148,700
Dividend Yield (%) d - Price / Cash In Hand g 12.104 Treasury Shares h -
Market Cap (M) 659.870 Enterprise Value (M) 682.259
Piotroski F Score 1 Exchange Code KROS Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 52.3
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 22 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Apr 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KEROS THERAPEUTICS INC NASDAQ 659.870 - - -26.5354 -
Industry Pharmaceuticals: Major NASDAQ 1,692.381 114.250 1786.655 2.9485 1.159
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 126,322.466 38.825 38.825 1.9095 2.330
Local Peer ROYALTY PHARMA PLC NASDAQ 28,919.147 12.314 12.314 - -
Local Peer REPLIGEN CORP NASDAQ 6,597.318 308.130 284.698 6.1671 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 5,184.471 - - 22.6745 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 5,058.470 - - -30.4127 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,852.048 6.935 6.266 0.7977 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 4,276.210 - - 3.2985 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,044.593 - - 14.0432 -
Local Peer ALLAKOS INC NASDAQ 3,334.640 - - 6.9756 -
Local Peer OPKO HEALTH INC NASDAQ 2,692.713 - - 1.7388 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 2,518.419 - - 6.5424 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,496.218 - - 6.5396 -
Other Local Peers APELLIS PHARMACEUTICALS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), GOSSAMER BIO INC (NASDAQ), PETIQ INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), AC IMMUNE SA (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), BEYONDSPRING INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), IMARA INC (NASDAQ), DURECT CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), VERU INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), IMMUNIC INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), HARROW HEALTH INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEDIWOUND LTD (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), LANTERN PHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), EYENOVIA INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), EDESA BIOTECH INC (NASDAQ), MANNATECH INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 375,086.578 24.809 21.851 6.1195 2.632
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 214,658.891 30.456 21.508 - 2.117
Global Peer MERCK & CO INC NYSE 193,674.193 19.676 19.087 7.3907 2.963
Global Peer PFIZER INC NYSE 187,919.899 11.549 11.901 2.8907 4.300
Global Peer ABBVIE INC NYSE 170,647.382 21.761 20.337 -23.0137 3.805
Global Peer ELI LILLY AND COMPANY NYSE 156,341.728 33.710 28.255 50.7802 1.580
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 141,095.270 105.253 189.712 - 2.548
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 129,946.287 37.786 136.212 2.6036 2.880
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 118,613.926 20.314 19.741 14.8289 1.738
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 100,119.822 16.896 20.758 - 4.887
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), SINOPHARM (HKEx), CANSINOBIO-B (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINARES PHARMA (HKEx), HENLIUS-B (HKEx), AKESO-B (HKEx), HEPALINK (HKEx), CMS (HKEx), ADC THERAPEUTICS SA (NYSE), OCUMENSION-B (HKEx), TRAD CHI MED (HKEx), CHINAGRANDPHARM (HKEx), INNOCARE-B (HKEx), HYGEIA HEALTH (HKEx), SSY GROUP (HKEx), UNITED LAB (HKEx), ZYMEWORKS INC (NYSE), CSTONE PHARMA-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), JUNSHI BIO-B (HKEx), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), IGBB (Bursa), SHINEWAY PHARM (HKEx), Kimia Farma Tbk. (IDX), TOT BIOPHARM-B (HKEx), FUSEN PHARM (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), BSTEAD (Bursa), LANNETT CO INC (NYSE), CH BIOTECH SER (HKEx), DAWNRAYS PHARMA (HKEx), PHARMA (Bursa), ZHONGZHIPHARM (HKEx), BIOMX INC (NYSE American), IX Biopharma (SGX), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), KOTRA (Bursa), PAK FAH YEOW (HKEx), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), NC HEALTHCARE (HKEx), Hyphens Pharma (SGX), ONCOSIL MEDICAL LIMITED (ASX), IP (SET), Phapros Tbk. (IDX), PALLA PHARMA LTD (ASX), RACE ONCOLOGY LTD (ASX), NOVA (Bursa), NEP INTERLONG (HKEx), WAI YUEN TONG (HKEx), INVION LTD (ASX), ANNOVIS BIO INC (NYSE American), TBG DIAGNOSTICS LTD (ASX), NOXOPHARM LTD (ASX), PURAPHARM (HKEx), SANAI HEALTH GP (HKEx), EXTRAWELL PHAR (HKEx), AGEX THERAPEUTICS INC (NYSE American), JCT (SET), IMMURON LIMITED (ASX), BIOHLDG (Bursa), MEDLAB CLINICAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), PHARMAXIS (ASX), SINOLIFE UTD (HKEx), EXOPHARM LTD (ASX), ACRUX (ASX), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), SUNZEN (Bursa), CELLMID LIMITED (ASX), CRESO PHARMA LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), SUDA PHARMACEUTICALS LTD (ASX), Pharmesis Intl (SGX), FARMAFORCE LTD (ASX), FIJI KAVA LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.870
-5.40 %
10 Days --5.250
-13.82 %
20 Days --2.810
-7.90 %
Medium Term Return 3 Months -+9.520
+40.98 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 19.100 - 42.260 Change From 1 Year Low +13.650 % Change From 1 Year Low (%) +71.47
Change From 1 Year High -9.510 % Change From 1 Year High (%) -22.50
2 Years Range 19.100 - 42.260 Change From 2 Years Low +13.650 % Change From 2 Years Low (%) +71.47
Change From 2 Years High -9.510 % Change From 2 Years High (%) -22.50
5 Years Range 19.100 - 42.260 Change From 5 Years Low +13.650 % Change From 5 Years Low (%) +71.47
Change From 5 Years High -9.510 % Change From 5 Years High (%) -22.50
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Keros Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on treatments for rare muscle diseases. The company was founded in 2015 and is headquartered in Lexington, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
10 Jul 2020 33.190 33.580 31.360 32.750 101,381 -
09 Jul 2020 34.600 36.560 33.210 33.430 40,401 -
08 Jul 2020 33.510 34.770 33.050 34.400 71,019 -
07 Jul 2020 34.680 35.170 33.560 33.710 30,355 -
06 Jul 2020 36.370 36.370 34.040 34.620 66,775 -
02 Jul 2020 36.810 37.780 34.800 35.800 75,491 -
01 Jul 2020 36.069 39.204 35.510 36.460 182,955 -
30 Jun 2020 37.750 38.750 36.160 37.510 82,700 -
29 Jun 2020 39.530 40.019 37.390 38.000 78,164 -
26 Jun 2020 40.850 41.500 37.695 38.630 899,904 -
25 Jun 2020 39.540 42.260 39.360 40.390 150,383 -
24 Jun 2020 40.700 41.916 37.000 39.000 141,330 -
23 Jun 2020 38.090 41.980 37.500 40.210 220,418 -
22 Jun 2020 38.200 40.200 36.310 37.650 181,659 -
19 Jun 2020 36.800 40.630 35.910 38.520 465,189 -
18 Jun 2020 35.000 37.000 33.820 36.770 121,147 -
17 Jun 2020 36.090 37.000 35.250 35.290 114,386 -
16 Jun 2020 36.670 37.000 35.570 35.940 107,932 -
15 Jun 2020 34.180 39.115 33.980 35.560 119,300 -
12 Jun 2020 33.400 35.625 33.400 34.300 43,508 -
11 Jun 2020 34.340 34.340 33.025 33.720 156,510 -
10 Jun 2020 35.540 36.200 34.504 35.520 84,927 -
Summary
Current 2 Weeks
(26 Jun 2020 to 10 Jul 2020)
40.850 41.500 31.360 32.750 1,629,145 -
Previous 2 Weeks
(12 Jun 2020 to 25 Jun 2020)
33.400 41.500 31.360 40.390 1,665,252 -
4 Weeks from
(14 May 2020 to 11 Jun 2020)
28.250 41.500 27.156 33.720 1,180,054 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.